Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment.

glioblastoma magnetic resonance imaging molecular markers multicentric glioblastoma multifocal glioblastoma

Journal

The neuroradiology journal
ISSN: 2385-1996
Titre abrégé: Neuroradiol J
Pays: United States
ID NLM: 101295103

Informations de publication

Date de publication:
10 Aug 2023
Historique:
medline: 10 8 2023
pubmed: 10 8 2023
entrez: 10 8 2023
Statut: aheadofprint

Résumé

Multifocal and multicentric glioblastoma (GBM) or collectively, m-GBM, is an imaging diagnosis present in up to 34% of patients with GBM. Compared to unifocal disease, patients with m-GBM have worse outcomes owing to the enhanced aggressive nature of the disease and its resistance to currently available treatments. To improve the understanding of its complex behavior, many associations have been established between the radiologic findings of m-GBM and its gross histology, genetic composition, and patterns of spread. Additionally, the holistic knowledge of the exact mechanisms of m-GBM genesis and progression is crucial for identifying potential targets permitting enhanced diagnosis and treatment. In this review, we aim to provide a comprehensive summary of the cumulative knowledge of the unique molecular biology and behavior of m-GBM and the association of these features with neuroimaging.

Identifiants

pubmed: 37559514
doi: 10.1177/19714009231193162
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19714009231193162

Auteurs

Maguy Farhat (M)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gregory N Fuller (GN)

Section of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Max Wintermark (M)

Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Caroline Chung (C)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Vinodh A Kumar (VA)

Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Melissa Chen (M)

Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Classifications MeSH